Integrating the Latest Data and Guidelines in the Management of HIV: Strategies for Optimizing Clinical and Economic Outcomes

A continuing medical education activity provided by NAMCP and AAMCN

Novel Treatment Advances and Approaches in Management of HIV is a three-part webinar series

This is Part 1 of the series focusing on the latest data and guidelines in the management of HIV

This activity is an archive from the webinar held December 9, 2020

This activity is valid from January 1, 2021 to January 1, 2023

 

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from
ViiV Healthcare

Description:
HIV is a lentivirus that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). HIV infection leads to low levels of CD4+ T cells through a number of specific mechanisms. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections. The CDC estimates that 1,218,400 people in the US aged 13 years and older are living with HIV infection and an estimated 6,955 people died in 2019. Fortunately, several new therapies have become available recently, and more are set to become available soon.

Upon completion of this activity, participants will be able to:

  • Examine the clinical burden of HIV, including factors that contribute to poor prognosis and increased costs

  • Compare and contrast new and emerging antiretroviral therapies (ART) based on the latest evidence for their efficacy, safety, and adherence potential

  • Apply recent clinical trial data to identify appropriate patient populations for new and emerging 2-drug regimens, including long-acting ART

  • Explore the role of newer therapies for heavily treatment-experienced (HTE) adults with multidrug-resistant HIV-1 infection

  • Evaluate patient-specific factors, including age, comorbidities, concomitant medications, and adherence challenges, in making decisions about HIV therapy selection

     

Faculty: Timothy J. Wilkin MD, MPH
Associate Professor of Medicine
Weill Cornell Medical College

Disclosure:

Dr. Wilkin has received grants/research support from ViiV Healthcare/GlaxoSmithKline and Merck. His presentation has been peer reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jeremy Williams has no real or perceived financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This activity is supported by an educational grant from
ViiV Healthcare

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue